PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Disease

Alcoholic Liver Disease (ald)

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 27, 2026 · JOURNAL ARTICLE

Bioactive molecule-derived covalent organic frameworks as biocompatible scaffolds for targeted AKR1B10 inhibition in alcoholic liver disease.

Biomaterials

This is a preclinical study combining transcriptomic analysis, virtual screening, and chemical synthesis followed by testing in animal models, raising mechanistic questions about AKR1B10 and COF scaffolds rather than establishing clinical efficacy.

Hypothesis-GeneratingMicrornas Jialu Zhuang Juan Wang

Reported

ALD patient cohort size33

Healthy control cohort size23

Number of inhibitors identified4

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support